Low dose inhaled fluticasone propionate compared with montelukast in children 6-12 years old Source: Eur Respir J 2003; 22: Suppl. 45, 535s Year: 2003
Efficiency of fluticasone propinate with salmeterol in asthmatic children during 1 years Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Efficacy of fluticasone propionate in infants younger than two years with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005
LATE-BREAKING ABSTRACT: Safety of salmeterol/fluticasone propionate (FSC) compared to fluticasone propionate (FP) in 4-17 yr olds with asthma Source: International Congress 2016 – Paediatric asthma: from amniotic fluid to dirty streets Year: 2016
Evaluation of long-term safety, growth and efficacy of fluticasone propionate 100mcg bd compared with sodium cromoglycate 5mg qds in asthmatic children aged 12-47 months Source: Eur Respir J 2002; 20: Suppl. 38, 219s Year: 2002
Efficacy and safety of once-daily (OD) fluticasone furoate (FF) 50mcg over 24 weeks in adults and adolescents with persistent asthma Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013
Once-daily tiotropium Respimat® add-on therapy improves PEF in participants aged 6-17 years with symptomatic asthma Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016
Impact of age on extra-fine particle hydrofluoroalkane beclometasone dipropionate versus fluticasone propionate outcomes in asthmatic children Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013
Safety profile of ciclesonide as compared with fluticasone propionate in the treatment of children and adolescents with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 346s Year: 2004
Efficacy and tolerability of formoterol Turbuhaler in 6–11 year old children with asthma, not adequately controlled with inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 430s Year: 2002
The TORCH (TOwards a Revolution in COPD Health) study: salmeterol/ fluticasone propionate (SFC) is well tolerated in patients with COPD over three years Source: Eur Respir J 2006; 28: Suppl. 50, 34s Year: 2006
"Stepping down" in mild-to-moderate asthmatic children, being well controlled while receiving low doses of inhaled corticosteroids (ICS): nedocromil sodium (NS) vs. fluticasone propionate (FP) 100 mcg/day given either twice Source: Eur Respir J 2006; 28: Suppl. 50, 713s Year: 2006
Efficacy and safety of inhaled corticosteroids in combination with a long-acting beta2-agonist in asthmatic children under age 5 Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016
Bioavailability of inhaled fluticasone propionate via chambers/masks in young children Source: Eur Respir J 2012; 39: 97-103 Year: 2012
Ciclesonide and fluticasone propionate show comparable efficacy in children and adolescents with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 346s Year: 2004
Bioavailability of inhaled fluticasone propionate via chambers/masks in young children Source: Eur Respir J 2011; 39: 97-103 Year: 2012
Is low dose inhaled fluticasone propionate safe in young children with asthma? Source: Annual Congress 2008 - Preschool wheezing: advances in diagnosis, phenotyping and therapy Year: 2008
Comparative effectiveness analysis: Extra-fine particle hydrofluoroalkane beclomethasone dipropionate vs fluticasone propionate with spacer in children Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013
A comparison of nebulized budesonide, intramuscular and oral dexamethasone in the treatment of croup among children aged 6-36 months Source: Eur Respir J 2003; 22: Suppl. 45, 284s Year: 2003
Efficacy and safety of once-daily (OD) fluticasone furoate (FF) in adults and adolescents with moderate-to-severe persistent asthma Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013